![]() |
Breast Cancer |
Free Subscription
5 Ann Surg Oncol |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Breast Cancer is free of charge.
ASO Visual Abstract: Impact of Time to Surgery Post Neoadjuvant Chemotherapy on
Breast Cancer Outcomes: A Retrospective Study of Patients Enrolled in the I-SPY 2
Clinical Trial.
Ann Surg Oncol. 2025 Aug 29. doi: 10.1245/s10434-025-18131.
PubMed
Breast Cancer Incidence Among Patients Undergoing Chest Masculinization Surgery:
A Scoping Review.
Ann Surg Oncol. 2025 Aug 28. doi: 10.1245/s10434-025-18156.
PubMed
Abstract available
ASO Visual Abstract: Impact of Second Opinions on Time to Treatment of Breast
Cancer.
Ann Surg Oncol. 2025 Aug 27. doi: 10.1245/s10434-025-18180.
PubMed
ASO Visual Abstract: Comparing Survival Differences Between Patients Undergoing
Breast-Conserving Therapy Versus Total Mastectomy as a First Treatment for Early
Stage Breast Cancer.
Ann Surg Oncol. 2025 Aug 27. doi: 10.1245/s10434-025-18217.
PubMed
ASO Visual Abstract: Neoadjuvant Chemotherapy is Not Associated with Improved
Overall Survival in Metaplastic Breast Cancer Regardless of Tumor Subtype.
Ann Surg Oncol. 2025 Aug 26. doi: 10.1245/s10434-025-18181.
PubMed
Paclitaxel-induced Peripheral Neuropathy and Quality of Life: Sub-analysis of the
MICHEL Study.
Anticancer Res. 2025;45:3827-3833.
PubMed
Abstract available
Opsoclonus-myoclonus Syndrome in a Female Breast Cancer Patient: A Case Report
and Literature Review.
Anticancer Res. 2025;45:4037-4045.
PubMed
Abstract available
Prevalence of Incidental Breast Cancer and Precursor Lesions in Carriers of
Pathogenic Germline Variants Undergoing Risk-Reducing Mastectomy.
Anticancer Res. 2025;45:3749-3760.
PubMed
Abstract available
Influence of Caffeic Acid Phenethyl Ester on Osteoblastic Cell Behavior in
Coculture With Breast Adenocarcinoma Cells.
Anticancer Res. 2025;45:3719-3726.
PubMed
Abstract available
Psychological Stress Versus Outcome in Patients With Breast Disease and Breast
Cancer: A Prospective 25-year Follow-up Study in Patients With Breast Cancer
Symptoms.
Anticancer Res. 2025;45:3817-3826.
PubMed
Abstract available
Impact of Fentanyl and Remifentanil on Immune Response in Breast Cancer Patients
Post-surgery.
Anticancer Res. 2025;45:3761-3771.
PubMed
Abstract available
Association between polygenic risk and survival in breast cancer patients.
BMC Cancer. 2025;25:1393.
PubMed
Patients need information on the risk of second cancer after early breast cancer.
BMJ. 2025;390:r1584.
PubMed
Risk of second cancer after early breast cancer is low, study finds.
BMJ. 2025;390:r1819.
PubMed
Second primary cancers in breast cancer survivors.
BMJ. 2025;390:r1798.
PubMed
Second cancers in 475 000 women with early invasive breast cancer diagnosed in
England during 1993-2016: population based observational cohort study.
BMJ. 2025;390:e083975.
PubMed
Abstract available
Relation knowledge distillation 3D-ResNet-based deep learning for breast cancer
molecular subtypes prediction on ultrasound videos: a multicenter study.
Br J Cancer. 2025 Aug 26. doi: 10.1038/s41416-025-03146.
PubMed
Abstract available
Risk factors for early-onset radiodermatitis in patients with locally advanced
breast cancer: a comparative analysis of volumetric modulated arc therapy and
intensity-modulated radiotherapy.
Breast Cancer. 2025 Aug 27. doi: 10.1007/s12282-025-01762.
PubMed
Abstract available
Risk of endometrial cancer among breast cancer survivors in Japan: a matched
cohort study.
Breast Cancer. 2025 Aug 27. doi: 10.1007/s12282-025-01769.
PubMed
Abstract available
The impact of adjuvant radiotherapy on borderline and malignant phyllodes tumors
of the breast.
Breast Cancer. 2025;32:1006-1012.
PubMed
Abstract available
Alcohol consumption and breast lesions: targets for risk-based screening in
high-risk Italian women.
Breast Cancer. 2025;32:970-978.
PubMed
Abstract available
Major anatomic variations of the lateral upper arm lymphatic pathway in a healthy
female population.
Breast Cancer. 2025;32:1125-1131.
PubMed
Abstract available
Development of a deep learning-based automated diagnostic system (DLADS) for
classifying mammographic lesions - a first large-scale multi-institutional
clinical trial in Japan.
Breast Cancer. 2025;32:1115-1124.
PubMed
Abstract available
Validation of the predictive ability for recurrence and the clinical utility of
the 95-gene classifier (95GC) through an integrated analysis of five studies.
Breast Cancer. 2025;32:1075-1087.
PubMed
Abstract available
Tumor Immune Response as a Biomarker for Metastasis-Free Survival of Breast
Cancer and Immune Checkpoint Inhibition Therapy: A Retrospective Cohort Study.
Breast Cancer (Auckl). 2025;19:11782234251363665.
PubMed
Abstract available
Human Epidermal Growth Factor Receptor 2-Low Breast Cancer: Prevalence Rate and
Scoring Concordance Among Pathologists.
Breast Cancer (Auckl). 2025;19:11782234251363664.
PubMed
Abstract available
Evaluation of the Prognostic Value of Obesity, Vitamin D Concentrations, and
Systemic Inflammatory Response Indexes (SIRI, SII, PIV) in Patients With Breast
Cancer Scheduled for Neoadjuvant Treatment.
Breast Cancer (Auckl). 2025;19:11782234251369463.
PubMed
Abstract available
Breast Cancer (Dove Med Press)
Safety Profile and Predictors of Adverse Events of Incadronate Disodium in
Treating Breast Cancer Patients with Bone Metastases: A Retrospective Study.
Breast Cancer (Dove Med Press). 2025;17:727-739.
PubMed
Abstract available
Characterization of the tumor immune microenvironment in pregnancy-associated
breast cancer through multiplex immunohistochemistry and transcriptome analyses.
Breast Cancer Res. 2025;27:154.
PubMed
Abstract available
Longitudinal changes in metabolism-related metrics and breast cancer risk: a
general population study.
Breast Cancer Res. 2025;27:155.
PubMed
Abstract available
Pre-diagnostic serum metabolome and breast cancer risk: a nested case-control
study.
Breast Cancer Res. 2025;27:156.
PubMed
Abstract available
Neoadjuvant response stratification based on complete, partial, and no response
in HR-positive/HER2-positive breast cancer.
Breast Cancer Res Treat. 2025 Aug 28. doi: 10.1007/s10549-025-07812.
PubMed
Abstract available
Beyond the 5-year mark: adherence to and continuation of extended adjuvant
endocrine therapy in non-metastatic breast cancer patients.
Breast Cancer Res Treat. 2025 Aug 27. doi: 10.1007/s10549-025-07811.
PubMed
Abstract available
Transcriptomic and microenvironment characteristics of triple-negative breast
cancer under three different neoadjuvant treatment regimens.
Breast Cancer Res Treat. 2025 Aug 27. doi: 10.1007/s10549-025-07810.
PubMed
Abstract available
BRCA testing utilization among commercially insured women with breast or ovarian
cancer.
Breast Cancer Res Treat. 2025;213:291-298.
PubMed
Abstract available
Carboplatin, gemcitabine, and mifepristone for advanced breast and
recurrent/persistent epithelial ovarian cancer.
Breast Cancer Res Treat. 2025;213:347-354.
PubMed
Abstract available
Prediction of upstaging in DCIS: the dominant role of pathological over imaging
risk factors.
Breast Cancer Res Treat. 2025;213:325-334.
PubMed
Abstract available
Axillary dissection is avoidable in most cT1N0 triple-negative & HER2+ breast
cancers treated with upfront surgery.
Breast Cancer Res Treat. 2025;213:355-363.
PubMed
Abstract available
Changes in HER2low and HER2-ultralow status in 47 advanced breast carcinoma core
biopsies, matching surgical specimens, and their distant metastases assessed by
conventional light microscopy, digital pathology, and artificial intelligence.
Breast Cancer Res Treat. 2025;213:397-408.
PubMed
Abstract available
Cancer Epidemiol Biomarkers Prev
Lifetime Sunlight Exposure and Risk of Breast Cancer: A Population-based incident
Case-Control Study.
Cancer Epidemiol Biomarkers Prev. 2025.
PubMed
Abstract available
The Role of Adjuvant Radiation Therapy in Treating Older Breast Cancer Patients
With Low Adherence to Endocrine Therapy.
Clin Breast Cancer. 2025 Jul 30:S1526-8209(25)00225.
PubMed
Abstract available
Receptor Discordance During the Treatment Course of Patients With Metastatic
Breast Cancer: Results From the SONABRE Registry.
Clin Breast Cancer. 2025 Jul 30:S1526-8209(25)00217.
PubMed
Abstract available
Prognostic Outcomes by Axillary Approach in Lobular and Ductal Breast Cancer With
Sentinel Node Macrometastases: A Retrospective Cohort Study.
Clin Breast Cancer. 2025 Aug 5:S1526-8209(25)00219.
PubMed
Abstract available
FDA Approval Summary: Datopotamab deruxtecan-dlnk for treatment of patients with
unresectable or metastatic, HR-positive, HER2-negative breast cancer.
Clin Cancer Res. 2025 Aug 27:10.1158/1078-0432.CCR-25-1388.
PubMed
Abstract available
Cryptotanshinone instigates ferroptosis to inhibit the development of
tamoxifen-resistant breast cancer via the AMPK induced BECN1-SLC7A11 complex
axis.
Exp Cell Res. 2025;451:114726.
PubMed
Abstract available
A mass cytometry-based lens on DNA damage repair in circulating tumor cells from
breast cancer patients.
Int J Cancer. 2025 Aug 29. doi: 10.1002/ijc.70105.
PubMed
Loss of Angulin-1/LSR promotes vasculogenic mimicry and epithelial-mesenchymal
transition in breast cancer.
J Biol Chem. 2025 Aug 27:110635. doi: 10.1016/j.jbc.2025.110635.
PubMed
Abstract available
Reply to: "Rethinking Treatment Priorities in Estrogen Receptor-Low Breast
Cancer" and "CDK4/6 Inhibitors in Estrogen Receptor-Low Breast Cancer".
J Clin Oncol. 2025 Aug 28:JCO2501688. doi: 10.1200/JCO-25-01688.
PubMed
Rethinking Treatment Priorities in Estrogen Receptor-Low Breast Cancer.
J Clin Oncol. 2025 Aug 28:JCO2501176. doi: 10.1200/JCO-25-01176.
PubMed
CDK4/6 Inhibitors in Estrogen Receptor-Low Breast Cancer.
J Clin Oncol. 2025 Aug 28:JCO2500836. doi: 10.1200/JCO-25-00836.
PubMed
Effect of low-dose tamoxifen on benign gynecological and breast conditions in a
phase III trial in non-invasive breast cancer.
J Natl Cancer Inst. 2025 Aug 28:djaf250. doi: 10.1093.
PubMed
Abstract available
Predicting Breast Reconstruction Readmission, Reoperation, and Prolonged Length
of Stay: A Machine Learning Approach.
J Surg Oncol. 2025;132:345-353.
PubMed
Abstract available
Longitudinal Modeling in Surgical Oncology Research: A Primer Examining
Patient-Reported Outcomes.
J Surg Oncol. 2025;132:294-307.
PubMed
Abstract available
Single-cell RNA sequencing reveals different cellular states in malignant cells
and the tumor microenvironment in primary and metastatic ER-positive breast
cancer.
NPJ Breast Cancer. 2025;11:95.
PubMed
Abstract available
The association between young age at metastatic breast cancer diagnosis and
overall survival in the EMBRACE study.
NPJ Breast Cancer. 2025;11:96.
PubMed
Abstract available
Decoding the adaptive survival mechanisms of breast cancer dormancy.
Oncogene. 2025 Aug 27. doi: 10.1038/s41388-025-03529.
PubMed
Abstract available
Correction: COL5A1 promotes triple-negative breast cancer progression by
activating tumor cell-macrophage crosstalk.
Oncogene. 2025 Aug 28. doi: 10.1038/s41388-025-03554.
PubMed
Effectiveness of radiofrequency and exercise-based rehabilitation on symptoms
associated with pelvic floor dysfunction in breast cancer patients: A study
protocol.
PLoS One. 2025;20:e0330156.
PubMed
Abstract available
GATA3 promotes ferroptosis resistance by repressing integrin beta1 signaling.
Proc Natl Acad Sci U S A. 2025;122:e2427304122.
PubMed
Abstract available
Quantitative Pharmacokinetic Mapping with AI: Toward More Generalizable Response
Prediction in Breast Cancer MRI.
Radiol Artif Intell. 2025;7:e250550.
PubMed
Thank you for your interest in scientific medicine.